Latest filing published 17 Nov 2016 for Cipher Pharmaceuticals Inc., €481.
This profile gathers the share dealings of Brian Rosenberger in Cipher Pharmaceuticals Inc. Between 14 May 2015 and 15 November 2016, the trades on record add up to 10 filings.
Every open-market trade on record is a sale: 1 sale. The amount is not disclosed for 1 filing. Outside the open market, there are 7 share grants and 1 option exercise. In 2016 alone, the filings show no purchases and 1 sale.
The newest entry dates from 17 November 2016: a share grant of €481, in Cipher Pharmaceuticals Inc. Typically, a trade is published a median of 5 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations